Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.

Larson SR, Chin J, Zhang X, Brown LG, Coleman IM, Lakely B, Tenniswood M, Corey E, Nelson PS, Vessella RL, Morrissey C.

Clin Exp Metastasis. 2014 Feb;31(2):247-56. doi: 10.1007/s10585-013-9625-2. Epub 2013 Nov 17.

PMID:
24242705
[PubMed - indexed for MEDLINE]
2.

VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer.

Goel HL, Chang C, Pursell B, Leav I, Lyle S, Xi HS, Hsieh CC, Adisetiyo H, Roy-Burman P, Coleman IM, Nelson PS, Vessella RL, Davis RJ, Plymate SR, Mercurio AM.

Cancer Discov. 2012 Oct;2(10):906-21. doi: 10.1158/2159-8290.CD-12-0085. Epub 2012 Jul 9.

PMID:
22777769
[PubMed - indexed for MEDLINE]
3.

Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.

Putzke AP, Ventura AP, Bailey AM, Akture C, Opoku-Ansah J, Celiktaş M, Hwang MS, Darling DS, Coleman IM, Nelson PS, Nguyen HM, Corey E, Tewari M, Morrissey C, Vessella RL, Knudsen BS.

Am J Pathol. 2011 Jul;179(1):400-10. doi: 10.1016/j.ajpath.2011.03.028. Epub 2011 May 4.

PMID:
21703419
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.

Zhang S, Wang X, Osunkoya AO, Iqbal S, Wang Y, Chen Z, Müller S, Chen Z, Josson S, Coleman IM, Nelson PS, Wang YA, Wang R, Shin DM, Marshall FF, Kucuk O, Chung LW, Zhau HE, Wu D.

Oncogene. 2011 Dec 15;30(50):4941-52. doi: 10.1038/onc.2011.199. Epub 2011 May 30.

PMID:
21625216
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The effects of aging on the molecular and cellular composition of the prostate microenvironment.

Bianchi-Frias D, Vakar-Lopez F, Coleman IM, Plymate SR, Reed MJ, Nelson PS.

PLoS One. 2010 Sep 1;5(9). pii: e12501. doi: 10.1371/journal.pone.0012501.

PMID:
20824135
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Sun S, Sprenger CC, Vessella RL, Haugk K, Soriano K, Mostaghel EA, Page ST, Coleman IM, Nguyen HM, Sun H, Nelson PS, Plymate SR.

J Clin Invest. 2010 Aug;120(8):2715-30. doi: 10.1172/JCI41824. Epub 2010 Jul 19.

PMID:
20644256
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.

Mostaghel EA, Geng L, Holcomb I, Coleman IM, Lucas J, True LD, Nelson PS.

Cancer Res. 2010 Feb 15;70(4):1286-95. doi: 10.1158/0008-5472.CAN-09-2509. Epub 2010 Feb 2.

PMID:
20124490
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.

Morrissey C, Lai JS, Brown LG, Wang YC, Roudier MP, Coleman IM, Gulati R, Vakar-Lopez F, True LD, Corey E, Nelson PS, Vessella RL.

Prostate. 2010 Mar 1;70(4):412-24. doi: 10.1002/pros.21075.

PMID:
19866469
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.

Holcomb IN, Young JM, Coleman IM, Salari K, Grove DI, Hsu L, True LD, Roudier MP, Morrissey CM, Higano CS, Nelson PS, Vessella RL, Trask BJ.

Cancer Res. 2009 Oct 1;69(19):7793-802. doi: 10.1158/0008-5472.CAN-08-3810. Epub 2009 Sep 22.

PMID:
19773449
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Prostate cancer-associated gene expression alterations determined from needle biopsies.

Qian DZ, Huang CY, O'Brien CA, Coleman IM, Garzotto M, True LD, Higano CS, Vessella R, Lange PH, Nelson PS, Beer TM.

Clin Cancer Res. 2009 May 1;15(9):3135-42. doi: 10.1158/1078-0432.CCR-08-1982. Epub 2009 Apr 14.

PMID:
19366833
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.

Sung SY, Hsieh CL, Law A, Zhau HE, Pathak S, Multani AS, Lim S, Coleman IM, Wu LC, Figg WD, Dahut WL, Nelson P, Lee JK, Amin MB, Lyles R, Johnstone PA, Marshall FF, Chung LW.

Cancer Res. 2008 Dec 1;68(23):9996-10003. doi: 10.1158/0008-5472.CAN-08-2492.

PMID:
19047182
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.

Arnold RS, Sun CQ, Richards JC, Grigoriev G, Coleman IM, Nelson PS, Hsieh CL, Lee JK, Xu Z, Rogatko A, Osunkoya AO, Zayzafoon M, Chung L, Petros JA.

Prostate. 2009 Jan 1;69(1):1-11. doi: 10.1002/pros.20854.

PMID:
18850577
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate.

Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, Coleman IM, Eichner LJ, Nelson PS, Liu AY.

BMC Genomics. 2008 May 23;9:246. doi: 10.1186/1471-2164-9-246.

PMID:
18501003
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.

Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, Nelson PS, Coleman R, Wang YC, Corey E, Lange PH, Higano CS, Vessella RL.

Clin Exp Metastasis. 2008;25(4):377-88. Epub 2007 Oct 31.

PMID:
17972146
[PubMed - indexed for MEDLINE]
15.

Low-fat, low-glycemic load diet and gene expression in human prostate epithelium: a feasibility study of using cDNA microarrays to assess the response to dietary intervention in target tissues.

Lin DW, Neuhouser ML, Schenk JM, Coleman IM, Hawley S, Gifford D, Hung H, Knudsen BS, Nelson PS, Kristal AR.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2150-4.

PMID:
17932364
[PubMed - indexed for MEDLINE]
Free Article
16.

Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression.

Xu C, Graf LF, Fazli L, Coleman IM, Mauldin DE, Li D, Nelson PS, Gleave M, Plymate SR, Cox ME, Torok-Storb BJ, Knudsen BS.

Prostate. 2007 Nov 1;67(15):1621-9.

PMID:
17823924
[PubMed - indexed for MEDLINE]
17.

Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression.

He Y, Franco OE, Jiang M, Williams K, Love HD, Coleman IM, Nelson PS, Hayward SW.

Cancer Res. 2007 Sep 1;67(17):8188-97.

PMID:
17804732
[PubMed - indexed for MEDLINE]
Free Article
18.

Genetic background influences murine prostate gene expression: implications for cancer phenotypes.

Bianchi-Frias D, Pritchard C, Mecham BH, Coleman IM, Nelson PS.

Genome Biol. 2007;8(6):R117.

PMID:
17577413
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

Mostaghel EA, Page ST, Lin DW, Fazli L, Coleman IM, True LD, Knudsen B, Hess DL, Nelson CC, Matsumoto AM, Bremner WJ, Gleave ME, Nelson PS.

Cancer Res. 2007 May 15;67(10):5033-41.

PMID:
17510436
[PubMed - indexed for MEDLINE]
Free Article
20.

Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.

Coleman IM, Kiefer JA, Brown LG, Pitts TE, Nelson PS, Brubaker KD, Vessella RL, Corey E.

Neoplasia. 2006 Oct;8(10):862-78.

PMID:
17032503
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk